AI English summary of an SEC filing — figures as filed
Willis Towers Watson WTWWillis Towers Watson said revenue for Q3 2025 was $2,288 million, flat compared with $2,289 million in the prior-year period, and increased 5% on an organic basis. The company cited the sale of TRANZACT as the reason revenue was flat. Diluted earnings per share was $3.11 and adjusted diluted earnings per share was $3.07.
Key points
AI summaryWillis Towers Watson said revenue for Q3 2025 was $2,288 million, flat compared with $2,289 million in the prior-year period, and increased 5% on an organic basis. The company cited the sale of TRANZACT as the reason revenue was flat. Diluted earnings per share was $3.11 and adjusted diluted earnings per share was $3.07.
The company said income from operations for Q3 2025 was $418 million and operating margin was 18.3%. Adjusted operating income was $467 million, up 13% from the prior year, and adjusted operating margin was 20.4%, an increase of 230 basis points from the prior-year period.
Willis Towers Watson said Health, Wealth & Career segment revenue was $1,261 million, down 5%, and operating margin was 28.6%. Risk & Broking segment revenue was $1,007 million, up 7%, and operating margin was 18.8%.
The company said cash flows from operating activities for the 9 months ended September 30, 2025 were $1.0 billion and free cash flow was $838 million. Willis Towers Watson repurchased 1,848,098 of its outstanding shares for $600 million during Q3 and said it expects share repurchases of ~$1.5 billion in 2025.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.
Q3 2025 Revenue and Earnings Per Share
Willis Towers Watson said revenue for Q3 2025 was $2,288 million, flat compared with $2,289 million in the prior-year period, and increased 5% on an organic basis. The company cited the sale of TRANZACT as the reason revenue was flat. Diluted earnings per share was $3.11 and adjusted diluted earnings per share was $3.07.
Source · Based on the filing body and exhibits
Q3 Operating Income and Adjusted Operating Margin
The company said income from operations for Q3 2025 was $418 million and operating margin was 18.3%. Adjusted operating income was $467 million, up 13% from the prior year, and adjusted operating margin was 20.4%, an increase of 230 basis points from the prior-year period.
Source · Based on the filing body and exhibits
Q3 Segment Revenue and Operating Margin
Willis Towers Watson said Health, Wealth & Career segment revenue was $1,261 million, down 5%, and operating margin was 28.6%. Risk & Broking segment revenue was $1,007 million, up 7%, and operating margin was 18.8%.
Source · Based on the filing body and exhibits
9-Month Cash Flow and Q3 Share Repurchases
The company said cash flows from operating activities for the 9 months ended September 30, 2025 were $1.0 billion and free cash flow was $838 million. Willis Towers Watson repurchased 1,848,098 of its outstanding shares for $600 million during Q3 and said it expects share repurchases of ~$1.5 billion in 2025.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…